Learn more
Advanced Search

The Decade's Most Irresistible Opportunity... Don't Hesitate

By Dr. Steve Sjuggerud
Friday, July 18, 2008

On Wednesday I bought a variety of stocks...

I'd been trying to restrain myself. Just about everything has been in a downtrend this year. But things are just too irresistible now.

If you're a longtime reader, you know my criteria for buying... The ideal situation is when you can get all three of these together: 1) cheap, 2) hated, and 3) in the beginning of an uptrend.

Right now, the first two of our criteria are at "best in a decade" levels. So, though it feels extremely risky out there now, it's probably the least risky time to buy stocks in the last decade. Let me show you...

Just recently, the "Investors Intelligence" poll found that professional investors are more bearish than they've been at any time in the last decade. As the chart below shows, whenever investors get really bearish, stocks are generally near a short-term bottom.

I put a vertical line in whenever investor sentiment reached a bearish extreme. In hindsight, it always turned out to be good for a short-term rally in stocks. In bear markets, those rallies are short. In bull markets, the rallies are strong.

Stocks Are Hated... Time to Buy!
You think gas is expensive now? Consider this:

So judging by the Investors Intelligence poll, we have one of our three criteria: Stocks are "hated" right now.

Stocks also meet our "cheap" criteria... Stocks are cheaper now than they've been in more than a decade. According to Bloomberg, the forward price-to-earnings ratio for the Dow is only 12, and it's only 13 and change for the S&P 500 index.

The one criterion we're missing, of course, is the uptrend. No sector in the U.S. is up over the last 12 months, except a few oil stocks. It's been a horrible grind... until Wednesday of this week.

Tuesday felt like "capitulation" to me – investors finally threw in the towel. Wednesday's rally confirmed it. That we held on to those gains on Thursday morning was further confirmation.

When it feels safest to buy – when everyone else is talking about it – it's often the most risky. In 2005, all the talk was how "you couldn't go wrong" in real estate. In 1999, it was stocks. Now it feels like "you can't go right" investing in stocks – which is usually when it's least risky. Sounds convoluted, but it's usually true.


And if that happens – if we see the uptrend – I'll be buying more... We'll have all three buying criteria in place. That rarely happens, and we should take advantage of it.While we don't have confirmation of the uptrend yet, we do have two of the three things I want to see – and they're more attractive now than they've been in over a decade. It wouldn't surprise me at all to see stocks start a nice rally from here.

If it happens, don't hesitate. Buy.

Good investing,

Steve

Editor's note: Steve Sjuggerud is a regular contributor to DailyWealth, a free investment newsletter focused on the world's best contrarian opportunities. We write with a simple belief in mind: You don't have to take big risks to make big money with your investments. 







A POTENTIAL 500% BIOTECH RALLY IS AROUND THE CORNER

More on the "acting well" biotechnology sector...

As we've covered before, the biotech sector is a speculator's best friend. The investing public just loves a potential cure for cancer. So biotech bull markets are spectacular... often returning 300%-500%. A small stake in a biotech rally will make your entire year. A large stake will make your retirement.

We could be at the start of one of those great biotech bull markets. Several weeks ago, we ran a chart of the PowerShares Biotech ETF (PBE). While the broad market crashed in May and June, the PBE held like a rock.

Today's chart is another sign that a biotech bull market may be around the corner. It's the past year in the S&P Biotech Index ETF (XBI). This fund is full of midsized biotech companies with actual sales... sales a weak economy won't wreck.

The XBI hasn't just "held like a rock" during the past three months, it has gained 12%. For a sector with a risky reputation, this performance is amazing. The fuse is sparking on the biotech rocket.


recent articles
  • How Americans Should React to the Fannie Mae Bailout
    By Porter Stansberry Thursday, July 17, 2008
    I'm certain the government will do whatever it takes to ensure Fannie and Freddie continue to operate – but that doesn't mean bailing out the shareholders...


  • This Gadget Will Revolutionize Our Power Supply
    By Tom Dyson Wednesday, July 16, 2008
    According to the North American Reliability Corporation, United States demand for peak electricity will increase by 135 gigawatts over the next decade...
     
    But supply will only rise by 77 gigawatts. If these projections are correct, there will be a major shortage of electricity within the next 10 years...



  • The Best-Performing Stock Manager in America This Year
    By Dr. Steve Sjuggerud Tuesday, July 15, 2008
    Back in 1980, contrary to every other prognosticator out there, Leuthold was optimistic. He predicted inflation would fall to 3%. He predicted oil prices would calm down. And he predicted stocks and bonds would perform well. It was just brilliant stuff.


  • A Visit to the World's Next Agricultural Superpower
    By Tom Dyson Monday, July 14, 2008
    The world's largest agricultural firms all have operations in Brazil's soybean complex. I saw operations owned by Archer Daniels Midland, Bunge, Monsanto, Syngenta, John Deere, and many others.


  • An Extraordinary Income Opportunity in the Energy Market
    By Chris Mayer Saturday, July 12, 2008